DR. RACHEL WENNER RUZANIC M.D.
Prescription History 1073708608
Dermatology in St Cloud, MN

NPI Status: Active since September 06, 2007

Contact Information

1900 CENTRACARE CIRCLE
CENTRACARE CLINIC- HEALTH PLAZA SPECIALTIES
ST CLOUD, MN
ZIP 56303
Phone: (320) 229-4924

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RACHEL WENNER RUZANIC M.D., an active Dermatology specialist practicing in St Cloud, MN. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 694 documented patient claims. Among these therapy options, the most frequently utilized medication is Triamcinolone Acetonide, which accounts for 202 claims alone.


Amoxicillin

Generic Formulation: AmoxicillinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 11
30-Day Fills 25.7
Days Supply 747
MN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply210
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.7% less volume than the regional standard for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $110.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.03

State Avg Cost Per Claim

$3.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.

Therapeutic Applications

Amoxicillin is used to treat a wide variety of bacterial infections. This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning.

Cephalexin

Generic Formulation: CephalexinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 108
MN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.8
Peer Average Days Supply337
Conservative Utilization

This provider writes prescriptions for this formulation 25.9% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $123.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.18

State Avg Cost Per Claim

$7.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Clindamycin Phosphate

Generic Formulation: Clindamycin PhosphateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 22
30-Day Fills 24.3
Days Supply 666
MN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills25.0
Peer Average Days Supply691
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,017.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$46.24

State Avg Cost Per Claim

$68.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain type of vaginal infection (bacterial vaginosis) in women who are not pregnant. Clindamycin is an antibiotic which works by stopping the growth of bacteria.

Clobetasol Propionate

Generic Formulation: Clobetasol PropionateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 24
30-Day Fills 26.7
Days Supply 664
MN State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills35.9
Peer Average Days Supply917
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,325.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.22

State Avg Cost Per Claim

$85.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid.

Clotrimazole

Generic Formulation: ClotrimazoleSpecialty: Dermatology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.5
Days Supply 501
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills17.0
Peer Average Days Supply333
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $505.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.29

State Avg Cost Per Claim

$29.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.

Therapeutic Applications

Clotrimazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and other fungal skin infections (candidiasis). This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Clotrimazole is an azole antifungal that works by preventing the growth of fungus.

Desonide

Generic Formulation: DesonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 18
30-Day Fills 19.0
Days Supply 439
MN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.7
Peer Average Days Supply610
Conservative Utilization

This provider writes prescriptions for this formulation 28.0% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,967.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$109.33

State Avg Cost Per Claim

$79.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Desonide reduces the swelling, itching and redness that can occur in these types of conditions. Desonide is a mild corticosteroid.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 32
30-Day Fills 48.0
Days Supply 1,438
MN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills25.9
Peer Average Days Supply410
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 45.5% more claims than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,587.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.61

State Avg Cost Per Claim

$26.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Dupixent Syringe

Generic Formulation: DupilumabSpecialty: Dermatology
Provider Metrics Summary
Total Claims 38
30-Day Fills 38.0
Days Supply 1,064
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills17.1
Peer Average Days Supply475
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 137.5% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $139,157.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$3,662.03

State Avg Cost Per Claim

$3,691.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

Fluocinonide

Generic Formulation: FluocinonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 28
30-Day Fills 30.5
Days Supply 864
MN State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills33.4
Peer Average Days Supply878
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,643.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$58.71

State Avg Cost Per Claim

$70.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical glucocorticoid used in the treatment of ECZEMA.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, psoriasis, allergies, rash). Fluocinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

Humira Pen

Generic Formulation: AdalimumabSpecialty: Dermatology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 308
MN State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills21.3
Peer Average Days Supply596
Conservative Utilization

This provider writes prescriptions for this formulation 45.0% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $78,352.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,122.97

State Avg Cost Per Claim

$8,156.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

Therapeutic Applications

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

Hydroxychloroquine Sulfate

Generic Formulation: Hydroxychloroquine SulfateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 11
30-Day Fills 27.0
Days Supply 810
MN State Average Benchmarks
Peer Average Claims72.0
Peer Average 30-Day Fills167.9
Peer Average Days Supply4,988
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.7% less volume than the regional standard for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $608.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.33

State Avg Cost Per Claim

$84.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)

Therapeutic Applications

Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits.

Hydroxyzine Hcl

Generic Formulation: Hydroxyzine HclSpecialty: Dermatology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 580
MN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply785
Conservative Utilization

This provider writes prescriptions for this formulation 25.9% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $290.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.52

State Avg Cost Per Claim

$21.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Imiquimod

Generic Formulation: ImiquimodSpecialty: Dermatology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.6
Days Supply 347
MN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills30.2
Peer Average Days Supply810
Conservative Utilization

This provider writes prescriptions for this formulation 27.3% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,109.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$69.32

State Avg Cost Per Claim

$50.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.

Therapeutic Applications

This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.

Ketoconazole

Generic Formulation: KetoconazoleSpecialty: Dermatology
Provider Metrics Summary
Total Claims 74
30-Day Fills 84.2
Days Supply 2,372
MN State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills41.4
Peer Average Days Supply1,095
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 94.7% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,660.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.43

State Avg Cost Per Claim

$30.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.

Therapeutic Applications

This medication is used to control dandruff. Use of this medication may help to relieve the flaking, scaling and itching associated with dandruff. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Ketoconazole 2% shampoo is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs.

Metronidazole

Generic Formulation: MetronidazoleSpecialty: Dermatology
Provider Metrics Summary
Total Claims 44
30-Day Fills 46.5
Days Supply 1,241
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.0
Peer Average Days Supply121
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 175.0% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,844.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$87.38

State Avg Cost Per Claim

$35.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.

Therapeutic Applications

This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).

Minocycline Hcl

Generic Formulation: Minocycline HclSpecialty: Dermatology
Provider Metrics Summary
Total Claims 29
30-Day Fills 57.0
Days Supply 1,614
MN State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills25.9
Peer Average Days Supply715
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 52.6% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,529.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$52.76

State Avg Cost Per Claim

$38.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

Therapeutic Applications

This medication is used to treat acne or rosacea. Minocycline belongs to a class of drugs known as tetracycline antibiotics. However, it is not used to treat skin infections. It helps decrease pimples and red bumps that happen with acne or rosacea.

Mometasone Furoate

Generic Formulation: Mometasone FuroateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 339
MN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply733
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $422.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.17

State Avg Cost Per Claim

$58.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.

Therapeutic Applications

Mometasone is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school.

Spironolactone

Generic Formulation: SpironolactoneSpecialty: Dermatology
Provider Metrics Summary
Total Claims 14
30-Day Fills 18.0
Days Supply 540
MN State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills78.5
Peer Average Days Supply2,296
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.0% less volume than the regional standard for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $269.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.27

State Avg Cost Per Claim

$13.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

Therapeutic Applications

Spironolactone is used to treat high blood pressure and heart failure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic).

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: Dermatology
Provider Metrics Summary
Total Claims 22
30-Day Fills 26.3
Days Supply 766
MN State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills30.2
Peer Average Days Supply578
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $223.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.14

State Avg Cost Per Claim

$6.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Tretinoin

Generic Formulation: TretinoinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills18.2
Peer Average Days Supply499
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,010.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$154.66

State Avg Cost Per Claim

$172.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).

Therapeutic Applications

This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells.

Triamcinolone Acetonide

Generic Formulation: Triamcinolone AcetonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 202
30-Day Fills 293.5
Days Supply 8,260
MN State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills33.5
Peer Average Days Supply783
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 573.3% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,127.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.48

State Avg Cost Per Claim

$10.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Therapeutic Applications

This medication is used in a variety of conditions such as allergic disorders, arthritis, gout, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Talk to your doctor about the risks and benefits of triamcinolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Triamcinolone is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling.

Valacyclovir

Generic Formulation: Valacyclovir HclSpecialty: Dermatology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 69
MN State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills28.8
Peer Average Days Supply604
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $145.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.21

State Avg Cost Per Claim

$46.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES.

Therapeutic Applications

Valacyclovir is used to treat infections caused by certain types of viruses. In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. RACHEL WENNER RUZANIC M.D. provides transparency into local medical care patterns within St Cloud, MN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Dermatology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.